Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones

Kyung Eun Han, Woo Suk Chung, Tae im Kim, Sekyung Kim, Terry Kim, Eung Kweon Kim

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Purpose: To compare the epithelial wound healing response of two preservative-free fluoroquinolones, moxifloxacin and levofloxacin, in patients who underwent cataract surgery. Materials and Methods: In this prospective, evaluator-masked, randomized clinical trial, 59 eyes of 50 patients who underwent cataract surgery were enrolled. Patients were randomized to receive moxifloxacin 0.5% (n=32 eyes) or levofloxacin 0.5% (n=27 eyes). All patients instilled moxifloxacin or levofloxain four times daily for 1 week prior to surgery and 2 weeks after surgery. The epithelial wound healing status in the corneal incision site was scanned with a raster scan mode of fourier-domain optical coherence tomography (FD-OCT). The number of eyes showing epithelial defect images and average number of corneal epithelial defect cuts per eye were compared between groups. All patients were evaluated on postoperative days 1, 2, 3, and 10. Results: On postoperative days 1, 2, and 3, the number of eyes showing epithelial defects in FD-OCT was not statistically different (all p>0.05). The average number of corneal epithelial defect cuts was also not statistically different between the two groups (all p>0.05). No eyes showed epithelial defects on postoperative day 10 in either group. Conclusion: There were no differences on epithelial wound healing comparing these two different fluoroquinolones at the incision site of cataract surgery.

Original languageEnglish
Pages (from-to)197-202
Number of pages6
JournalYonsei Medical Journal
Volume55
Issue number1
DOIs
StatePublished - Jan 2014

Keywords

  • Cataract surgery
  • Epithelial wound healing
  • Levofloxacin
  • Moxifloxacin

Fingerprint

Dive into the research topics of 'Epithelial wound healing after cataract surgery comparing two different topical fluoroquinolones'. Together they form a unique fingerprint.

Cite this